DJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ dropped 0.18% to $5.51 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 0.60% to 18,190.29 and the Dow Jones Industrial Average rising 0.62% to 42,175.11.
This was the stock's second consecutive day of losses.
Inovio Pharmaceuticals Inc. closed $9.24 below its 52-week high ($14.75), which the company reached on April 1st.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 0.49% to $161.39, Statera Biopharma Inc. (STAB) rose 100.00% to $0.00, and Pfizer Inc. $(PFE)$ rose 0.14% to $28.97.
Trading volume (358,111) eclipsed its 50-day average volume of 295,281.
Data source: Dow Jones Market Data, FactSet. Data compiled September 26, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
September 26, 2024 17:30 ET (21:30 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。